Home  /  Resource Library  /  Long term Follow up of Patients with Relapsed or Refractory Non-Hodgkin Lymphoma Treated with Venetoclax in a Phase I, First-in-Human Study

Long term Follow up of Patients with Relapsed or Refractory Non-Hodgkin Lymphoma Treated with Venetoclax in a Phase I, First-in-Human Study

Long term results of a phase I trial investigating venetoclax for treatment of relapsed non-Hodgkin lymphomas.